Ankur Patel

Jan 6, 2025 | ankur9455.medium.com | Ankur Patel

Ankur patel · Follow Just now -- पढ़ना - एक प्रार्थना का रूप पढ़ना न केवल शब्दों को देखने का एक तरीका है, बल्कि यह एक ध्यान का रूप भी है। यह हमें अपने वर्तमान से दूर ले जाता है और हमें एक नए दुनिया में ले जाता है। पढ़ने की शक्ति: - हमें अपने बारे में भूलने में मदद करती है - हमें दूसरों के दृष्टिकोण से दुनिया देखने का मौका देती है - हमें अपनी सोच को विस्तारित करने में मदद करती है - हमें दूसरों से प्यार करने की अनुमति देती है पढ़ना हमें यह याद दिलाता है कि हम स्थायी नहीं हैं और ब्रह्मांड के...

Dec 23, 2024 | nationalobserver.com | Patricia Lane |Ankur Patel

These in-their-own-words pieces are told to Patricia Lane and co-edited with input from the interviewee for the purpose of brevity. Ankur Patel, a 21-year-old nursing student from Terrace, British Columbia, is helping nurses see care for the planet as care for people. Tell us about your projects. I am on the board of the Canadian Nursing Students' Association.

Dec 5, 2024 | digitalcommons.library.tmc.edu | Christo Mathew |Ankur Patel |George Cholankeril |Avegail Flores

BACKGROUND: Cardiovascular disease commonly affects advanced liver disease patients. They undergo cardiac interventions to improve cardiac outcomes. Cirrhosis increases complication risk, including bleeding, renal and respiratory failure, and further decompensation, including death, posing a clinical dilemma to proceduralists. Predicting outcomes is crucial in managing patients with cirrhosis.

Dec 5, 2024 | digitalcommons.library.tmc.edu | Christo Mathew |Ankur Patel |George Cholankeril |Avegail Flores

BACKGROUND: Cardiovascular disease commonly affects advanced liver disease patients. They undergo cardiac interventions to improve cardiac outcomes. Cirrhosis increases complication risk, including bleeding, renal and respiratory failure, and further decompensation, including death, posing a clinical dilemma to proceduralists. Predicting outcomes is crucial in managing patients with cirrhosis.

Jul 2, 2024 | accp1.onlinelibrary.wiley.com | Dawoon Jung |David Procaccini |Jennifer Roem |Ankur Patel

Conflicts of Interest Jogarao V.S. Gobburu is a co-founder of Pumas-AI which commercializes Pumas and Lyv and a co-founder of Vivpro Corp. which commercializes R&D Intelligence Assistant (RIA) software. Melania M. Bembea's institution received NIH funding for ECMO research unrelated to this work. None of the authors are members of the institutional Pharmacy and Therapeutics Committee that make decisions on pharmaceutical product selection for clinical care.